Dangerous drug related to severe bleeding issues and in some cases even death…
It is rare that we get excited to take on a case here at the Edward M Bernstein and Associates law firm. Generally it is simply a matter of evaluating the facts and aggressively helping our injured clients. We love helping injury and accident victims in Las Vegas, but most of the injuries we deal with are not life and death, but more related to pain, suffering and work loss.
When we began hearing rumors about Pradaxa a little over a year ago, our fears were raised. Here was a drug which had serious side effects that were un-reverseable and the maker seemed more intent on marketing the drug, rather than warn the doctors of the serious side effects patients were experiencing.
In one six month sampling we looked at, there were over 270,000 prescriptions written with 237 deaths and over 1,000 serious major medical complications. This is about .45% of patients taking this dangerous drug either died or had a serious medical issue. That’s about 1 for every 200 people.
Why were we excited to get the first Ptadaxa case in Nevada? Because we know how dangerous this drug has been to some people (even if great number of people were totally fine). With all medications come risk, but the risk in the Pradaxa cases is excessive and compounded by Boehringer Ingelheim’s silence to inform patients of these substantial risks.
If you have a loved one who died or had a major bleeding issue while on Pradaxa, please give us a call today to see if you have a case!
Critics of Pradaxa claim that manufacturer, Boehringer Ingelheim GmbH, would have discovered the extent of the drug’s dangerous side effects if the company had not rushed the drug through the approval process to beat competing drugs to the market. It is the drug maker’s responsibility to conduct thorough testing for potential deadly side effects and warn users of the extent of all risks. Boehringer did not uphold this responsibility and those individuals and families affected by their negligence should consider speaking with legal counsel to understand their rights.
Symptoms include but are not limited to:
• Brain Hemorrhaging/Bleeding
• Gastrointestinal (GI) Bleeding
• Kidney Bleeding
• Internal Bleeding
• Heart Attack/ Cardiac Injury
Hundreds of deaths worldwide have already been attributed to this dangerous drug. Causes of death from Pradaxa use have occurred from:
• Having a medical condition such as an ulcer that began bleeding and could not be stopped
• A traffic accident or trauma resulting in unstoppable bleeding
• Not being able to receive emergency surgery due to risk of uncontrollable bleeding
• Heart attack (Myocardial infarction)
If you or someone you love has suffered excessive and uncontrollable bleeding, or a heart attack after taking Pradaxa, you deserve compensation. Call us immediately at (702)240-0000 to see if you have a case. – Edward M Bernstein and Associates
A British drug company has agreed to pay $750 million to settle criminal and civil complaints that it knowingly sold contaminated baby ointment and an ineffective antidepressant for years.
According to a New York Time article, “GlaxoSmithKline sold 20 drugs with questionable safety that were made at a huge plant in Puerto Rico that for years was rife with contamination… Among the drugs affected were Paxil, an antidepressant; Bactroban, an ointment; Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet, an acid reflux drug. No patients were known to have been sickened, although such cases would be difficult to trace.”
The article also says that Cheryl D. Eckard, the company’s quality manager, warned the company of the problems but the company fired her instead of addressing them. For her whistle-blowing efforts, Eckard will get $96 million from the federal government.
If you ever experience dangerous side effects from a drug, call my office at 702-240-0000 or go to www.edbernstein.com.
-Edward M Bernstein and Associates
October 26, 2010
Glaxo to Pay $750 Million for Sale of Bad Products
By GARDINER HARRIS and DUFF WILSON
GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines.
Find this article at: NY Times
Several lawsuits and a motion to consolidate have been filed against the Johnson & Johnson unit after the company recalled thousands of its hip replacement systems. The recall came after a study showed that the ASR Hip Resurfacing System and the ASR XL Acetabular System had alarmingly high failure rates.
The Food and Drug Administration says the diet drug Meridia is being pulled from the market because of heart attack and stroke risks. The company that makes Meridia, Abbott Laboratories, says it disagrees with the FDA’s evaluation of Meridia but says it will comply with the federal agency’s request.
The FDA says the drug, approved in 1997, raises the risk of heart attack and stroke but “offers little benefit.”
Documents released by lawmakers say Johnson & Johnson, the drug company that recalled millions of children’s Tylenol products earlier this year, may have known of problems and planned to quietly get those drugs off the shelves months before the official recall.